Asymmetric dimethylarginine reflects cumulative inflammatory burden in rheumatoid arthritis

Cumulative inflammation associates with asymmetric dimethylarginine in rheumatoid arthritis: a 6 year follow-up study

(2014) Aamer Sandoo et al.   RHEUMATOLOGY

Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study

(2013) Andrzej Surdacki et al.   Cardiovascular Diabetology

Predictors of asymmetric dimethylarginine levels in patients with rheumatoid arthritis: the role of insulin resistance

(2013) T Dimitroulas et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Classical cardiovascular disease risk factors associate with vascular function and morphology in rheumatoid arthritis: a six-year prospective study

(2013) Aamer Sandoo et al.   ARTHRITIS RESEARCH & THERAPY

Clinical remission following treatment with tumour necrosis factor-alpha antagonists is not accompanied by changes in asymmetric dimethylarginine in patients with rheumatoid arthritis

(2012) Aamer Sandoo et al.   CLINICAL BIOCHEMISTRY

DimethylatedL-arginine analogues versus autoantibodies in early rheumatoid arthritis

(2012) M Korkosz et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Elevated dimethylarginine dimethylaminohydrolase (DDAH) activity in rheumatoid arthritis and spondyloarthritis

(2011) Kristine Chobanyan-Jürgens et al.   NITRIC OXIDE-BIOLOGY AND CHEMISTRY

Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality—An update on patient populations with a wide range of cardiovascular risk

(2009) Rainer H. Böger et al.   PHARMACOLOGICAL RESEARCH

Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients

(2009) M. Turiel et al.   RHEUMATOLOGY